Eli Lilly and Company vs Novartis AG
Eli Lilly and Company is worth $1.061T, 3.5× the $299.439B market cap of Novartis AG. Updated daily.
| Metric | Novartis AGNVS  | |
|---|---|---|
| Market cap | $1.061T | $299.439B |
| Global rank | #1 | #2 |
| Share price | $1,189.41 | $157.54 |
| Change | -2.11% | +1.90% |
| Revenue | $65.179B | $56.674B |
| Net income | $20.640B | $13.984B |
| Country | United States | Switzerland |
| Sector | Healthcare | Healthcare |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is Eli Lilly and Company bigger than Novartis AG?
- Eli Lilly and Company has a market cap of $1.061T against $299.439B for Novartis AG, making it 3.5 times as valuable.
- Which company earns more, LLY or NVS?
- Eli Lilly and Company reported net income of $20.640B and Novartis AG reported $13.984B in their most recent annual periods.